+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country- Product Image
North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country- Product Image
Sale

North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country

  • PDF Icon

    Report

  • 164 Pages
  • October 2020
  • Region: North America
  • The Insight Partners
  • ID: 5204864
UP TO OFF until Jun 30th 2024
Description Jump to:
Cancer Vaccines Market for Dendritic Cells Cancer Vaccines Segment to Grow at Fastest CAGR during Forecast Period

According to the new market research study on “Cancer Vaccines Market to 2027 - North America Analysis and Forecast - by Technology, Type, Indication, and End Use” the market is expected to reach US$6,626.6 million in 2027 from US$1,875.7 million in 2019; it is estimated to grow at a CAGR of 17.5% from 2020 to 2027. The report highlights trends prevailing in the North America Cancer Vaccines Market and the drivers and restraints pertaining to the market growth.

Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines. The in recombinant cancer vaccines segment held the largest share of the market in 2019. Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.

The North America Cancer Vaccines market growth is mainly attributed to factors such as growing prevalence of cancer, and rising government initiatives to prevent it. However, the challenges in cancer vaccines industry like expensive cost restrains the growth of the market.

AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Moderna, Inc., OncBioMune Pharmaceuticals Inc., MaxiVAX, Nouscom are among the leading companies operating in the Cancer Vaccines Market.

The report segments North America Cancer Vaccines market as follows:

By Technology
  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines

By Type
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccine

By Indication
  • Cervical Cancer
  • Prostate Cancer
  • Other Indications

By End-Use
  • Pediatrics
  • Adults

By Country
  • US
  • Canada
  • Mexico

Reasons to Buy
  • To understand the North America cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the North America cancer vaccines market
  • Efficiently plan M&A and partnership deals in the North America cancer vaccines market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the North America cancer vaccines market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Cancer Vaccines Market - By Technology
1.3.2 North America Cancer Vaccines Market - By Type
1.3.3 North America Cancer Vaccines Market - By Indication
1.3.4 North America Cancer Vaccines Market- By End Use
1.3.5 North America Cancer Vaccines Market- By Region
2. Cancer Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cancer Vaccines - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. North America Cancer Vaccines Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
5.2 Key Market Restraints
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
5.2.2 Higher Cost of Cancer Vaccines
5.3 Key Market Opportunities
5.3.1 Increasing Government support in Emerged Countries
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact analysis
6. Cancer Vaccines Market - Regional Analysis
6.1 North America Cancer Vaccines Market Revenue Forecast And Analysis
7. North America Cancer Vaccines Market Analysis - By Technology
7.1 Overview
7.2 Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%)
7.3 Dendritic Cells Cancer Vaccine
7.3.1 Overview
7.3.2 Dendritic Cells Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Recombinant Cancer Vaccines
7.5.1 Overview
7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antigen Cancer Vaccines
7.6.1 Overview
7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Whole Cell Cancer Vaccines
7.7.1 Overview
7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Viral Vector Cancer Vaccines
7.8.1 Overview
7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8. Cancer Vaccines Market Analysis - By Type
8.1 Overview
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
8.3 Preventive Cancer Vaccines
8.3.1 Overview
8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Therapeutic Cancer Vaccines
8.4.1 Overview
8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9. Cancer Vaccines Market Analysis - By Indication
9.1 Overview
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
9.3 Cervical Cancer
9.3.1 Overview
9.3.2 Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Prostate Cancer
9.4.1 Overview
9.4.2 Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Other Indications
9.5.1 Overview
9.5.2 Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10. Cancer Vaccines Market Analysis - By End Use
10.1 Overview
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
10.3 Pediatrics
10.3.1 Overview
10.3.2 Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Adults
10.4.1 Overview
10.4.2 Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
11. Cancer Vaccines Market - Geographic Analysis
11.1 North America: Cancer Vaccines Market
11.1.1 Overview
11.1.2 North America: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Cancer Vaccines Market, by Technology, 2018-2027 (USD Million)
11.1.4 North America: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.5 North America: Cancer Vaccines Market, by Indication, 2018-2027 (USD Million)
11.1.6 North America: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.7 North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.1.8 US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.8.3 US: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.8.4 US: Cancer Vaccines Market, by Technology2018-2027 (USD Million)
11.1.8.5 US: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.9 Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.9.3 Canada: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.9.4 Canada: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.9.5 Canada: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
11.1.10 Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Cancer Vaccines Market, by Type, 2018-2027 (USD Million)
11.1.10.3 Mexico: Cancer Vaccines Market, by Indication 2018-2027 (USD Million)
11.1.10.4 Mexico: Cancer Vaccines Market, by Technology 2018-2027 (USD Million)
11.1.10.5 Mexico: Cancer Vaccines Market, by End User, 2018-2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Cancer Vaccines Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 CSL Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ADURO BIOTECH INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bristol-Myers Squibb Company
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Dendreon
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Merck & Co., Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sanofi (Sanofi Pasteur)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 OSE Immunotherapeutics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of Terms
List of Tables
Table 1. North America Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 2. North America Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 5. Estimated Number of New Cancer Cases and Deaths, US, 2020
Table 6. US Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 8. US Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 9. US Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 13. Canada Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Incidence, Mortality and Prevalence by cancer site in 2018
Table 15. Mexico Cancer Vaccines Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Cancer Vaccines Market, by Indication - Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico Cancer Vaccines Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 19. Organic Developments Done By Companies
Table 20. Inorganic Developments Done By Companies
Table 21. Glossary of Terms, Cancer Vaccines Market
List of Figures
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Segmentation - By Region
Figure 3. North America Cancer Vaccines Market Overview
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019
Figure 5. Cancer Vaccines Market in US to Show Remarkable Growth During Forecast Period
Figure 7. North America PEST Analysis
Figure 8. Cancer Statistics, 2020
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 10. North America Cancer Vaccines Market - Revenue Forecast And Analysis - 2019-2027
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)
Figure 12. Dendritic Cells Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 21. Cervical Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Prostate Cancer: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Other Indications: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 25. Pediatrics: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Adults: Cancer Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. North America: Cancer Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 28. North America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 29. North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
Figure 30. US: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. Canada: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. Mexico: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
Figure 34. Growth Strategies Done by the Companies in the Market, (%)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom

Related Topics

Related Reports

Global Cancer Vaccine Market ,Vaccine Price, Dosage, Sales & Clinical Trials Outlook 2029 - Product Image

Global Cancer Vaccine Market ,Vaccine Price, Dosage, Sales & Clinical Trials Outlook 2029

  • Report
  • 840 Pages
  • Global
From
US cancer vaccine industry outlook to 2028 - Product Image

US cancer vaccine industry outlook to 2028

  • Report
  • 85 Pages
  • United States
From
Global Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Forecast 2024-2030 - Product Image

Global Cancer Vaccines Market by Technology (Antigen, Dendritic Cells, Recombinant Cancer Vaccines), Treatment Method (Preventive Vaccine, Therapeutic Vaccine), Application - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Cancer Vaccines Market Report 2023-2033 - Product Image

Cancer Vaccines Market Report 2023-2033

  • Report
  • 235 Pages
  • Global
From
Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cancer Vaccine Market Size, Share & Trends Analysis Report By Indication Type (Bladder, Cervical), By Vaccine Type (Preventive, Therapeutic), By Technology Type (Recombinant, Whole-cell), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.